<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Second Chances in Mineral Metabolism</title>
	<atom:link href="http://www.nephrologynow.com/publications/second-chances-in-mineral-metabolism/feed" rel="self" type="application/rss+xml" />
	<link>http://www.nephrologynow.com/publications/second-chances-in-mineral-metabolism</link>
	<description></description>
	<lastBuildDate>Tue, 24 Aug 2010 16:29:14 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
	<item>
		<title>By: Janice Cori Cobb</title>
		<link>http://www.nephrologynow.com/publications/second-chances-in-mineral-metabolism/comment-page-1#comment-150</link>
		<dc:creator>Janice Cori Cobb</dc:creator>
		<pubDate>Fri, 26 Feb 2010 19:55:08 +0000</pubDate>
		<guid isPermaLink="false">http://www.nephrologynow.com/?p=1368#comment-150</guid>
		<description>I am most intrigued with Dr. Myles Woolf&#039;s article concerning bone mineral metabolism, particularly with regard to the role of FGF23.  Inasmuch as increased Fibroblast growth factor (FGF23) production is associated with decreased renal function, might that increase, in and of itself, be a contributory agent of causation?  Also, of great interest, is the resurgence of increased dietary and supplemental cholecalciferol, both in its application to benefit optimal and appropriate bone mineral metabolism, and, also, its role in ameliorating interstitial nephritis.

I very much enjoy accessing the highly informative articles made available through &quot;Nephrology Now&quot;.

Kind regards,
Janice Cori Cobb</description>
		<content:encoded><![CDATA[<p>I am most intrigued with Dr. Myles Woolf&#8217;s article concerning bone mineral metabolism, particularly with regard to the role of FGF23.  Inasmuch as increased Fibroblast growth factor (FGF23) production is associated with decreased renal function, might that increase, in and of itself, be a contributory agent of causation?  Also, of great interest, is the resurgence of increased dietary and supplemental cholecalciferol, both in its application to benefit optimal and appropriate bone mineral metabolism, and, also, its role in ameliorating interstitial nephritis.</p>
<p>I very much enjoy accessing the highly informative articles made available through &#8220;Nephrology Now&#8221;.</p>
<p>Kind regards,<br />
Janice Cori Cobb</p>
]]></content:encoded>
	</item>
</channel>
</rss>
<!-- This Quick Cache file was built for (  www.nephrologynow.com/publications/second-chances-in-mineral-metabolism/feed ) in 0.94089 seconds, on Sep 7th, 2010 at 12:06 am UTC. -->
<!-- This Quick Cache file will automatically expire ( and be re-built automatically ) on Sep 8th, 2010 at 12:06 am UTC -->